About Bexarotene
Class: | Retinoid, Antineoplastic
Use: | Treatment of cutaneous T-cell lymphoma (CTCL) in patients who have received prior systemic therapy
Adult dose: | Initial dose of 300 mg/m²/day for 14 days, then may be adjusted based on tolerance and response; maximum dose is typically 400 mg/m²/day
Pediatric dose: | Safety and efficacy not established in pediatric patients; not recommended for use in children
Side effects: | Common side effects include headache, fatigue, nausea, vomiting, diarrhe
Drug Class
Retinoid, Antineoplastic
Uses & Indications
Treatment of cutaneous T-cell lymphoma (CTCL) in patients who have received prior systemic therapy
Storage Requirements
Store at room temperature (20°C to 25°C or 68°F to 77°F); protect from light and moisture
Manufacturer & Packaging
Manufacturer: Eisai Europe Limited, UNITED KINGDOM
Package Size
100's
Price & Supplier
Price in UAE: AED 9200.00
Dosage Information
Adult Dose
Initial dose of 300 mg/m²/day for 14 days, then may be adjusted based on tolerance and response; maximum dose is typically 400 mg/m²/day
Pediatric Dose
Safety and efficacy not established in pediatric patients; not recommended for use in children
Side Effects
Common side effects include headache, fatigue, nausea, vomiting, diarrhea, dry skin, and hyperlipidemia
Contraindications & Precautions
Contraindicated in patients with known hypersensitivity to Bexarotene or any component of the formulation; pregnancy (Category X)
Important Warnings
Monitor for signs of pancreatitis, hyperlipidemia, and thyroid dysfunction; may cause fetal harm; use effective contraception during treatment and for at least 1 month after discontinuation
Medical Disclaimer
This information is for educational purposes only and should not replace professional medical advice.
Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication.
The information presented here is specific to medicines available in UAE pharmacies and is regularly updated
to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.